[ Price : $8.95]
Akin Gump attorneys highlight major issues in the PDUFA 8 commitment letter that is now open for public comment.[ Price : $8.95]
MasterControl issues its 2026 life sciences regulatory readiness playbook demonstrating the significant ways in which the FDA Qual...[ Price : $8.95]
The U.S. Court of Appeals for the Fifth Circuit upholds FDAs decision to remove tirzepatide from the agencys drug shortage list, a...[ Price : $8.95]
Reed Smith attorney James Beck says courts so far have rejected all arguments citing the Supreme Courts Loper Bright decision as a...[ Price : $8.95]
Attorneys from Arnall Golden Gregory examine and offer advice on FDAs intensified scrutiny of drug advertising, advising companies...[ Price : $8.95]
A new report from Senate HELP chair Bill Cassidy (R-LA) targets FDA for allowing the abortion drug mifepristones Risk Evaluation a...[ Price : $8.95]
Rep. Lauren Boebert introduces legislation to remove some barriers to the development of botanical drugs.[ Price : $8.95]
Five stakeholders support an FDA proposal for an expedited IND pilot program and suggest ways to improve it.